<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="CSS/style.css">
    <title>Table</title>
</head>
<body>
	<h3>Table 1. Stem Cell Companies Active in Ophthalmology</h3>
	<table>
		<colgroup>
			<col style="width:10%">
			<col style="width:50%">
			<col style="width:10%">
			<col style="width:30%">
		</colgroup>
		<thead>
			<tr>
				<th>Company</th>
				<th>Collaborator(s)</th>
				<th>Cell Type</th>
				<th>Applications</th>
			</tr>
		</thead>
		<tbody>
			<tr>
				<td>Advanced Cell Technology Inc.(ACT)</td>
				<td>
					Oregon Health & Science University (OHSU)
					<ul>
						<li>Moorfields  Eyw Hosp.</li>
						<li>UCLA/Jules Stein</li>
						<li>Moorfields  Eyw Hosp.</li>
						<li>Moorfields  Eyw Hosp.</li>
						<li>Bascom Palmer.</li>
					</ul>
				</td>
				<td>
					hESCs
				</td>
				<td>
					RPE cells for retinal diseases,including Dry AMD <a href="">NCT01344993</a> and Stargardt's <a href="">NCT01345006</a> <a href="">NCT01469832</a> 
				</td>
			</tr>
			<tr>
				<td>AstraZeneca</td>
				<td>
					Univ. College London(UCL)
				</td>
				<td>
					hESCs
				</td>
				<td>
					Diabetic Retinopathy 
				</td>
			</tr>
			<tr>
				<td>Centecor/J&Jw/iScience Interventional</td>
				<td>
					<ul>
						<li>Retina Institute of CA</li>
						<li>Wills Eye Hospital</li>
					</ul>
				</td>
				<td>
					Adult SCs (CNTO 2746 from umbillical cord fluid)
				</td>
				<td>
					RPE cells for GA (atrophic dry AMD) <a href="">NCT01226628</a>
				</td>
			</tr>
			<tr>
				<td>Cell Cure Neuroscience</td>
				<td>
					TEVA
				</td>
				<td>
					hESCs
				</td>
				<td>
					RPE cells for dry AMD.
				</td>
			</tr>
			<tr>
				<td>
					CellSeed France SARL
				</td>
				<td>
					FGK Clinical Research GmbH
					<ul>
						<li>Universitatsklinkum,Erlangen,Germany</li>
					</ul>
				</td>
				<td>
					oral mucosa epithelial cells
				</td>
				<td>
					CAOMECS* for Corneal tissue repair in those with limbal cell deficiencies <a href="">NCT01489501</a> 
				</td>
			</tr>
			<tr>
				<td>Fundacion Clinic per a la Recerca Biomedica (Spain)</td>
				<td>
					<ul>
						<li>Hospital Clinic Barcelona</li>
						<li>Instituto Univ. Barraquer</li>
						<li>Instituto de Microcirugia Ocular </li>
					</ul>
				</td>
				<td>
					sclerocomeal progenitor cells from the limbus
				</td>
				<td>
					Replacement of damaged corneal cells <a href="">NCT01470573</a> 
				</td>
			</tr>
			<tr>
				<td>General Hosp of the Chinese People's Armed Police Force (China)</td>
				<td>

				</td>
				<td>
					unknown
				</td>
				<td>
					Optic Nerve Atrophy <a href="">ChiCTR-TNRC-11001-491</a>
				</td>
			</tr>
			<tr id="bottom-2">
				<td>International Stem Cell Corp. (ISCO)</td>
				<td>
					CytoCor -
					<ul>
						<li>Absorption Systems - US</li>
						<li>Sankara Nethralaya - India</li>
						<li>Automation Partnership - UK</li>
					</ul>
				</td>
				<td>
					hpSCs
				</td>
				<td>
					Corneal tissue for transplantation into degenerated corneas 
				</td>
			</tr>
			<tr id="bottom">
				<td></td>
				<td>
					CytoRet - UC Irvine
				</td>
				<td>
					hpSCs
				</td>
				<td>
					RPE cells and layered retinal structures for AMD 
				</td>
			</tr>
		</tbody>
	</table>
</body>
</html>


	